Results 81 to 90 of about 233,367 (176)

Chemotherapy of advanced dysgerminoma: trials of the Gynecologic Oncology Group.

, 1991
Between 1984 and 1989, 20 assessable patients with incompletely resected ovarian dysgerminoma were treated on two protocols of the Gynecologic Oncology Group (GOG). All patients received cisplatin, bleomycin, and either vinblastine or etoposide.
K D Hatch, S D Williams, J A Blessing, H D Homesley   +3 more
core   +1 more source

Ovarian dysgerminoma: clues to the radiological diagnosis. [PDF]

Diagn Interv Radiol, 2023
Amante S, Félix A, Cunha TM.
europepmc   +1 more source

Ovarian dysgerminoma [PDF]

, 2020
  +4 more sources

Ovarian Dysgerminoma - Challenging Presurgical Diagnosis and Mini-Mally Invasive Treatment. [PDF]

Arch Clin Med Case Rep, 2023
Otto K, Ebertz O, Matsingou C, Andrikos D, De Wilde RL, Krentel H.   +5 more
europepmc   +1 more source

KIT Gene Mutation and Amplification in Dysgerminoma of the Ovary

, 2010
BACKGROUND: Dysgerminoma, the ovarian counterpart of seminoma, is the most common type of malignant ovarian germ cell tumor. The role of KIT mutation and amplification in the development of dysgerminoma is not currently established.
Roth L. M., Cheng L., Abdul Karim F. W., Zhang S., Morton M. J., Lopez Beltran A., Wang M., Zheng W., MONTIRONI, RODOLFO, Mingsheng Wang, Rodolfo Montironi, Fadi W. Abdul Karim, Liang Cheng, Michael J. Morton, Wenxin Zheng, Antonio Lopez-Beltran, Shaobo Zhang, Lawrence M. Roth   +17 more
core   +1 more source

Ovarian dysgerminoma with a metastasis to para-aortic lymph node. [PDF]

Clin Case Rep, 2021
Kawase R, Suzuki S.
europepmc   +1 more source

Ovarian dysgerminoma with pseudo-Meigs syndrome: A case report. [PDF]

Medicine (Baltimore), 2021
Li X, Chen D, Jin X, Xu G, Hu B, Zeng X, Jin X.   +6 more
europepmc   +1 more source

Treatment Results of Ovarian Dysgerminoma

, 1996
Purpose: We tried to evaluate the clinical characteristics, the treatment methods, the results of treatments, and the patterns of failure in ovarian dysgerminoma retrospectively.
금기창, 성진실
core  

Outcome and Reproductive Function After Chemotherapy for Ovarian Dysgerminoma

, 1999
PURPOSE: To review the outcome for all patients with ovarian dysgerminoma treated at the M.D. Anderson Cancer Center who received bleomycin, etoposide, and cisplatin (BEP) and to assess the menstrual and reproductive function of those who received ...
Elvio G. Silva, Cynthia E. Herzog, Michele Follen Mitchell, J. Taylor Wharton, Molly Brewer, David M. Gershenson   +5 more
core   +1 more source

Diagnosis and management of a rare bilateral ovarian mixed germ cell tumor: a case report

Frontiers in Oncology
BackgroundMixed ovarian malignant germ cell tumors (MOGCTs) are rare neoplasms composed of two or more malignant germ cell components, representing less than 1% of all ovarian germ cell tumors.
Xuanling Li, Min You, Xiaoyun Zhang, Jingjing Wei, Guangyao Lin, Qianjue Tang, Lianwei Xu   +6 more
doaj   +1 more source